Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 21: 5Y Outcomes From the BIO-RESORT trial | drug eluting stent
Author(s): Eline H Ploumen Added: 2 years ago
In this short video, Dr Eline H Ploumen (Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, NL) discusses the 5-yearoutcomesfrom the BIO-RESORT trial. The randomized trial compared the ultrathin-strut and very thin-strut biodegradable polymer DES to thin-strut durable polymer DES. At 1-year follow-up, non-inferiority of the two novel DES was showed. Discussion Points: Rationale… View more

Intervention
Author(s): Nikolaos Konstantinidis , Georgios Sianos Added: 3 years ago
Coronary chronic total occlusions (CTOs) are identified in up to one-third of all patients referred for diagnostic coronary angiography,1 with an incidence increasing with age.2 CTOs still represent the most technically challenging lesion subset that interventional cardiologists face. The benefits of successful CTO recanalisation are related to improved survival,3,4 most notably in patients with… View more

Intervention
ESC 2018: Results From the BIOSCIENCE Study
Author(s): Thomas Pilgrim Added: 5 years ago
Dr Thomas Pilgrim (University of Bern, CH) discusses BIOSCIENCE -Randomized comparison of an ultrathin cobaltchromium biodegradable polymer sirolimus-eluting stent with a thin strut durable polymer everolimus-eluting stent for PCI. Filmed by Radcliffe Cardiology on site at ESC 2018, Munich. View more

Prevention & Chronic Conditions
Author(s): Robert Gil , Dobrin Vassilev , Jacek Bil Added: 3 years ago
The treatment of coronary bifurcation lesions (BL) is still challenging for interventional cardiologists, due to the relatively high-risk of the side branch (SB) closure and the increased long-term restenosis.1 The idea of a dedicated bifurcation stent (DBS) was proposed as a solution for problems associated with the BL treatment by means of a classical stent.1 Three groups of stents are… View more

Intervention
Author(s): Nicolaus Reifart , Mariann Gyöngyösi , Karl-Eugen Hauptmann , et al Added: 3 years ago
Coronary stent implantation is one of the most important developments in the field of percutaneous coronary revascularisation after the introduction of balloon angioplasty in 1977.1 The treatment of coronary artery disease (CAD) using a bare-metal stent (BMS) is considered effective; however, restenosis occurs in 15–35% of all cases, requiring repeated treatment.2–4 To overcome the restenosis… View more

Prevention & Chronic Conditions
Second - versus First-generation Drug-eluting Stents
Author(s): Kamal Chitkara , Anthony H Gershlick Added: 3 years ago
First-generation Stents Since drug-eluting stents (DES) received the CE mark in 2002 and the US Food and Drug Administration (FDA) approved the first DES in 2003, there has been a significant increase in the use of these devices. The advent of DES has revolutionised the field of interventional cardiology by having a major impact on patient care through their efficacy in reducing the need for… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli
Author(s): Marco Valgimigli Added: 1 year ago
ESC Congress 22 — Prof Marco Valgimigli (Cardiocentro Ticino Foundation, CH) joins us to share the 15-month results from the MASTER DAPT trial (NCT03023020). This randomised, multi-centre study compared abbreviated antiplatelet with prolonged antiplatelet regimen (aspirin and P2Y12i) aligned with current medical recommendation in high bleeding risk (HBR) patients who received biodegradable… View more

Anticoagulation

Intervention
Contemporary Techniques for Coronary Chronic Total Occlusions Revascularisation: Sharing Experience in a Global World
Author(s): Heinz Joachim Büttner , Masahisa Yamane , Nicolaus Reifart , et al Added: 3 years ago
Introduction and Objectives A symposium, chaired by Dr Heinz Joachim Büttner of Freiburg-Bad Krozingen (Germany) and Dr Masahisa Yamane of St Luke’s International Hospital (Tokyo, Japan) took place at EuroPCR, Paris on May 23rd, 2014. Its objectives were as follows: to learn how to improve the success of percutaneous intervention (PCI) in chronic total occlusion (CTO) by matching techniques to… View more

MI/ACS

Intervention
Author(s): Robin P Kraak , Maik J Grundeken , Robbert J de Winter , et al Added: 3 years ago
In the past three decades, significant progress has been made in the treatment of coronary artery disease. From the introduction of balloon angioplasty by Andreas Grüntzig in 19771 to metallic drugeluting stents with thin stent struts coated with cytotoxic or cytostatic drugs,2,3 with biocompatible/biodegradable polymers,4 with or without endothelial progenitor cell-capturing technology.5 However… View more

Imaging & Diagnostics

Intervention
Author(s): Katrina Mountfort Added: 3 years ago
Proceedings of two satellite symposia held at EuroPCR, Paris in May 2015 Although the latest polymeric drug-eluting stents (DES) have enhanced percutaneous coronary intervention (PCI) procedures, a substantial proportion of patients requiring percutaneous transluminal coronary angiography (PTCA) is elderly with numerous different comorbidities. This population requires use of effective DES that… View more

Intervention